Fenocor R 160mg/10mg Tablet is a combination medication containing Fenofibrate 160mg and Rosuvastatin 10mg, designed to manage lipid disorders effectively. Fenofibrate primarily works by activating peroxisome proliferator-activated receptors (PPARs), which help reduce triglycerides and increase high-density lipoprotein (HDL) cholesterol levels. Rosuvastatin, a potent statin, inhibits HMG-CoA reductase, an enzyme critical in cholesterol synthesis, thereby lowering low-density lipoprotein (LDL) cholesterol and total cholesterol levels. This dual-action formulation is particularly beneficial for patients with mixed dyslipidemia or those who require additional lipid control beyond monotherapy. Fenocor R is indicated to reduce the risk of cardiovascular events in patients with hyperlipidemia or hypertriglyceridemia, especially when lifestyle modifications such as diet and exercise are insufficient. The combination enhances lipid profile improvement by targeting multiple pathways involved in lipid metabolism. Patients should take this medication under medical supervision, as it may cause side effects such as muscle pain, liver enzyme abnormalities, or gastrointestinal discomfort. Regular monitoring of lipid levels, liver function, and renal parameters is recommended during therapy. Fenocor R 160mg/10mg Tablet offers a comprehensive approach to lipid management, contributing to cardiovascular risk reduction when used appropriately.